Skip to content

Optimization of Therapeutic Drug Monitoring of Vancomycin in Pediatric Patients With an Implanted Port Catheter

Optimization of Therapeutic Drug Monitoring of Vancomycin in Pediatric Patients With an Implanted Port Catheter

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03720132
Enrollment
10
Registered
2018-10-25
Start date
2014-06-30
Completion date
2018-09-30
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Related Blood Stream Infections

Keywords

Vancomycin, Therapeutic drug monitoring, Catheter related blood stream infections

Brief summary

The goal of this study is to verify whether extensive flushing of the port catheter in patients with catheter related blood stream infection will lead to correct vancomycin trough levels, taken via the port catheter and compared with simultaneously taken peripheral samples.

Detailed description

In this study, extensive flushing of the port catheter prior to blood sampling to determine vancomycin trough levels, will be compared with normal flushing. To ascertain correctness of the trough levels taken via the central catheter, sampling will occur through a peripheral catheter simultaneously. Flushing will be done with sodium chloride 0.9 % solution.

Interventions

PROCEDUREExtensive flushing of the port catheter

The port catheter will be flushed extensively with sodium chloride 0.9% before blood sampling. Blood sampling will occur through the central catheter and peripherally simultaneously.

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric patients with a port catheter * Treated with systemic vancomycin and/or vancomycin lock

Exclusion criteria

* Age \> 18 years * Active downgrading of care

Design outcomes

Primary

MeasureTime frameDescription
Vancomycin trough levels via port catheter and peripheral veinAt steady state i.e. approximately 36 hours after initation of the treatment or a change in doseVancomycin trough levels will be determined, both on peripheral blood and blood taken via the port catheter and will be compared.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026